NeoGenomics, Inc.
Status: Publicly traded
Direct answer
NeoGenomics, Inc. is publicly traded on NASDAQ under the ticker NEO.
NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, oncologists,...
Can you invest in NeoGenomics, Inc.?
Yes. NeoGenomics, Inc. is publicly traded on NASDAQ under the ticker NEO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for NeoGenomics, Inc.
Detailed equity research is provided by MarketSnap.